{
  "id": "ctis:2024-510718-34-00",
  "euct": "2024-510718-34-00",
  "title": "Study of Artificial Intelligence-based Personalized Rituximab Treatment Protocol in Membranous nephropathy - iRITUX",
  "publicTitle": "Study of Artificial Intelligence-based Personalized Rituximab Treatment Protocol in Membranous nephropathy - iRITUX",
  "fullTitle": "Study of Artificial Intelligence-based Personalized Rituximab Treatment Protocol in Membranous nephropathy",
  "shortTitle": "22-APN-01",
  "status": "Authorised",
  "statusCode": "4",
  "startDateEU": "2024-11-29",
  "decisionDate": "2024-09-09T17:19:59.143",
  "publishDate": "2026-02-21T02:41:51.898069591",
  "trialRegion": "EEA",
  "trialRegionCode": "1",
  "medicalConditions": [
    {
      "name": "Membranous nephropathy",
      "rareDisease": true
    }
  ],
  "therapeuticAreas": [
    {
      "code": "25",
      "name": "Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutics [E02]"
    }
  ],
  "trialCategory": {
    "phaseCode": "11",
    "categoryCode": "3",
    "lowIntervention": true
  },
  "duration": {
    "estimatedRecruitmentStartDate": "2024-10-01",
    "estimatedEndDate": "2031-10-01",
    "estimatedGlobalEndDate": null
  },
  "countries": [
    {
      "name": "France",
      "publicStatusCode": "4",
      "firstDecisionDate": "2024-09-09T17:19:59.143",
      "lastDecisionDate": "2026-02-20T12:22:06.411",
      "history": [
        {
          "source": "application_country_status",
          "applicationBusinessKey": "IN",
          "applicationType": "INITIAL",
          "status": "Authorised",
          "trialStatus": "Authorised",
          "decision": "authorized",
          "assessmentOutcome": "acceptable",
          "assessmentOutcomeDate": "2024-09-04",
          "date": "2024-09-09",
          "reportingStatusCode": "Authorised",
          "applicationStatusCode": "Authorised"
        },
        {
          "source": "application_country_status",
          "applicationBusinessKey": "SM-1",
          "applicationType": "SUBSTANTIAL MODIFICATION",
          "status": "Authorised",
          "trialStatus": "Authorised",
          "decision": "authorized",
          "assessmentOutcome": "acceptable",
          "assessmentOutcomeDate": "2025-03-03",
          "date": "2024-09-09",
          "reportingStatusCode": "Authorised",
          "applicationStatusCode": "Authorised"
        },
        {
          "source": "application_country_status",
          "applicationBusinessKey": "SM-2",
          "applicationType": "SUBSTANTIAL MODIFICATION",
          "status": "Authorised",
          "trialStatus": "Authorised",
          "decision": "authorized",
          "assessmentOutcome": "acceptable",
          "assessmentOutcomeDate": "2026-02-19",
          "date": "2024-09-09",
          "reportingStatusCode": "Authorised",
          "applicationStatusCode": "Authorised"
        },
        {
          "source": "application_decision",
          "applicationBusinessKey": "IN",
          "applicationType": "INITIAL",
          "status": "Authorised",
          "trialStatus": "Authorised",
          "decision": "authorized",
          "assessmentOutcome": "acceptable",
          "eventType": "decision",
          "date": "2024-09-09T17:19:59.143",
          "isRMS": true
        },
        {
          "source": "application_decision",
          "applicationBusinessKey": "SM-1",
          "applicationType": "SUBSTANTIAL MODIFICATION",
          "status": "Authorised",
          "trialStatus": "Authorised",
          "decision": "authorized",
          "assessmentOutcome": "acceptable",
          "eventType": "decision",
          "date": "2025-04-18T15:58:15.69",
          "isRMS": true
        },
        {
          "source": "application_decision",
          "applicationBusinessKey": "SM-2",
          "applicationType": "SUBSTANTIAL MODIFICATION",
          "status": "Authorised",
          "trialStatus": "Authorised",
          "decision": "authorized",
          "assessmentOutcome": "acceptable",
          "eventType": "decision",
          "date": "2026-02-20T12:22:06.411",
          "isRMS": true
        }
      ]
    }
  ],
  "applications": [
    {
      "id": "application:2024-510718-34-00:in",
      "businessKey": "IN",
      "type": "INITIAL",
      "status": "Authorised",
      "trialStatus": "Authorised",
      "submissionDate": "2024-05-27",
      "decisionDate": "2024-09-09",
      "decisions": [
        {
          "mscName": "France",
          "decisionDate": "2024-09-09T17:19:59.143",
          "decision": "authorized",
          "assessmentOutcome": "acceptable",
          "eventType": "decision",
          "applicationType": "INITIAL",
          "isRMS": true
        }
      ],
      "countryStatuses": [
        {
          "countryName": "France",
          "mscName": "France",
          "trialStatus": "Authorised",
          "decision": "authorized",
          "decisionDate": "2024-09-09",
          "firstDecisionDate": "2024-09-09",
          "assessmentOutcome": "acceptable",
          "assessmentOutcomeDate": "2024-09-04",
          "reportingStatusCode": "Authorised",
          "applicationStatusCode": "Authorised"
        }
      ]
    },
    {
      "id": "application:2024-510718-34-00:sm-1",
      "businessKey": "SM-1",
      "type": "SUBSTANTIAL MODIFICATION",
      "status": "Authorised",
      "trialStatus": "Authorised",
      "submissionDate": "2025-01-24",
      "decisionDate": "2025-04-18",
      "decisions": [
        {
          "mscName": "France",
          "decisionDate": "2025-04-18T15:58:15.69",
          "decision": "authorized",
          "assessmentOutcome": "acceptable",
          "eventType": "decision",
          "applicationType": "SUBSTANTIAL MODIFICATION",
          "isRMS": true
        }
      ],
      "countryStatuses": [
        {
          "countryName": "France",
          "mscName": "France",
          "trialStatus": "Authorised",
          "decision": "authorized",
          "decisionDate": "2024-09-09",
          "firstDecisionDate": "2024-09-09",
          "assessmentOutcome": "acceptable",
          "assessmentOutcomeDate": "2025-03-03",
          "reportingStatusCode": "Authorised",
          "applicationStatusCode": "Authorised"
        }
      ]
    },
    {
      "id": "application:2024-510718-34-00:sm-2",
      "businessKey": "SM-2",
      "type": "SUBSTANTIAL MODIFICATION",
      "status": "Authorised",
      "trialStatus": "Authorised",
      "submissionDate": "2026-01-16",
      "decisionDate": "2026-02-20",
      "decisions": [
        {
          "mscName": "France",
          "decisionDate": "2026-02-20T12:22:06.411",
          "decision": "authorized",
          "assessmentOutcome": "acceptable",
          "eventType": "decision",
          "applicationType": "SUBSTANTIAL MODIFICATION",
          "isRMS": true
        }
      ],
      "countryStatuses": [
        {
          "countryName": "France",
          "mscName": "France",
          "trialStatus": "Authorised",
          "decision": "authorized",
          "decisionDate": "2024-09-09",
          "firstDecisionDate": "2024-09-09",
          "assessmentOutcome": "acceptable",
          "assessmentOutcomeDate": "2026-02-19",
          "reportingStatusCode": "Authorised",
          "applicationStatusCode": "Authorised"
        }
      ]
    }
  ],
  "evidence": [
    {
      "id": "evidence:3862a741cf7770f248b5c832",
      "path": "authorizedApplication.authorizedPartI.trialDetails.clinicalTrialIdentifiers.fullTitle",
      "term": "artificial intelligence",
      "snippet": "Study of Artificial Intelligence-based Personalized Rituximab Treatment Protocol in Membranous nephropathy"
    },
    {
      "id": "evidence:b6ed0fdf098036f64c8eedf9",
      "path": "authorizedApplication.authorizedPartI.trialDetails.clinicalTrialIdentifiers.publicTitle",
      "term": "artificial intelligence",
      "snippet": "Study of Artificial Intelligence-based Personalized Rituximab Treatment Protocol in Membranous nephropathy - iRITUX"
    },
    {
      "id": "evidence:276431009326b811ce77ccf5",
      "path": "authorizedApplication.authorizedPartI.trialDetails.trialInformation.trialObjective.secondaryObjectives[14].secondaryObjective",
      "term": "machine learning",
      "snippet": "Model improvement through machine learning"
    }
  ],
  "official": {
    "retrieveUrl": "https://euclinicaltrials.eu/ctis-public-api/retrieve/2024-510718-34-00",
    "publicUrl": "https://euclinicaltrials.eu/ctis-public/view/2024-510718-34-00?lang=en"
  },
  "slug": "2024-510718-34-00",
  "firstObservedAt": "2026-07-23T11:19:41.794Z",
  "lastObservedAt": "2026-07-23T13:03:56.000Z",
  "dateModified": "2026-07-23",
  "materialFingerprint": "90f596a038213900c68072b7f9b59dacb1b2eb9cdd395ad87d2b7dafef47ac78"
}